Tw. Smith et al., COMPUTERIZED ANALYSIS OF TUMOR-CELL INTERACTIONS WITH EXTRACELLULAR-MATRIX PROTEINS, PEPTIDES, AND ENDOTHELIAL-CELLS UNDER LAMINAR-FLOW, Biotechnology and bioengineering, 50(5), 1996, pp. 598-607
Arrest and formation of stable adhesive interactions between circulati
ng cells and the endothelium or exposed subendothelial matrix are impo
rtant processes in many biological situations. We have developed a hig
hly sensitive hydrodynamic assay that utilizes a parallel-plate flow c
hamber, video microscopy, and digital image processing to separate and
measure the primary arrest and adhesion stabilization of flowing cell
s. Our data indicate that primary cell contact triggers secondary adhe
sion stabilization, and the secondary events are likely to be critical
to metastasis formation. To study the relationship between tumor cell
adhesion stabilization and organ-specific blood-borne metastasis, we
investigated the adhesion stabilization of metastatic murine RAW117 la
rge-cell lymphoma cells to the extracellular matrix proteins fibronect
in and vitronectin, several Arg-Gly-Asp (RGD) containing peptides, and
microvascular endothelial cells from the liver or lung. The highly li
ver metastatic RAW117-H10 subline showed the fastest stabilization to
fibronectin, vitronectin, and RGD peptides. Poorly metastatic RAW117-P
cells had stabilization times 3-10 times longer than for RAW117-H10 c
ells, while the lung- and liver-metastatic RAW117-L17 subline failed t
o stabilize at all. The adhesion stabilization of the RAW117-H10 cells
to the extracellular matrix proteins and RGD peptides was inhibited b
y anti-beta(3) integrin monoclonal antibodies and RGD peptides. In con
trast, the RAW117-L17 subline had the shortest stabilization time to u
nstimulated microvascular endothelial cells of the lung and hepatic si
nusoids, followed by RAW117-H10 cells and RAW117-P cells. Monoclonal a
ntibodies against the beta(3) integrin subunit and RGD peptides did no
t inhibit adhesion stabilization of RAW117-H10 cells to endothelial ce
lls, suggesting that different metastatic variants of large-cell lymph
oma cells use differing mechanisms to adhere to organ-specific endothe
lial cells. (C) 1996 John Wiley & Sons, Inc.